💡 Did you know? Emerging research shows that specific nutrients could play a key role in protecting against #Parkinson’s disease and slowing its progression. ✨ In our latest blog, we dive into the fascinating world of Vitamin B1 (Thiamine) and its potential as a therapeutic tool for Parkinson’s. From clinical studies to promising outcomes, we break it all down for you. 👉 Don’t miss out—read the full blog here: https://lnkd.in/eH68qvK7 #parkinsonsdisease #medicalresearch #therapy #killparkinson
Kill Parkinson
Gemeinnützige Organisationen
Berlin, Berlin 653 Follower:innen
Let's finally beat Parkinson's by pooling our patient knowledge & experience and sharing it with the best scientists
Info
Parkinson entwickelt sich zu einer weltweiten Plage & Pandemie. Inzwischen schätzt man, dass 10 Millionen Menschen weltweit erkrankt sind, die Zahlen entwickeln sich progressiv, auch gibt es immer mehr junge Erkrankte. Parkinson wurde vor über 200 Jahren entdeckt. Dennoch ist die Krankheit bis heute weder heilbar noch ist die neurodegenerative Entwicklung zu stoppen. Es gibt lediglich die Möglichkeit, die Symptome abzumildern. Von einer Impfung gegen Parkinson scheinen wir gefühlt noch weit entfernt zu sein. Die Forschung hat zwar inzwischen die Abläufe im Körper gut untersucht, aber auch durch die Pharma-finanzierte Incentivierung wird viel im Bereich der Behandlung der Symptome geforscht. Warum genau die idiopathische (ohne Ursache) Parkinson Variante bei Einzelnen entsteht, ist ungeklärt. Um einen Gegner, so sehen wir die Erkrankung, zu bekämpfen, muss man die Stärken und Schwächen der Krankheit besser verstehen. Daher haben wir als Parkinson-Patienten mit verschiedenen Neurologen und Parkinson-Experten gesprochen. Wir haben gefragt, was die Forschung der Erkrankungsgründe, die Entwicklung einer Heilmethode oder einer Impfung ermöglichen könnte. Wesentlich mehr strukturierte, digitalisierte und historische Patientendaten für die Forschung war einer der genannten Schlüssel. Forscher haben heute auf den ersten Blick durch Digitalisierung & KI stark verbesserte Möglichkeiten, „big data“ auszuwerten. Auf der anderen Seite steigen Datenschutzbestimmungen immer weiter und es ist schwer für Forscher größere und fachübergreifende Patientendaten zu nutzen. Dies ist für uns als Parkinson-Betroffene nicht zu akzeptieren. Unser Ziel ist es, Parkinson auszulöschen. www.kill-parkinson.org wird Parkinson-Patienten und Angehörigen ermöglichen, anonymisiert Informationen zur Lebens- und Krankheitsgeschichte abzugeben, die wir „open source“ für die Forschung zur Verfügung stellen. Wir arbeiten gemeinnützig und freuen uns daher über jeglichen Support unserer Vision.
- Website
-
https://linktr.ee/killparkinson
Externer Link zu Kill Parkinson
- Branche
- Gemeinnützige Organisationen
- Größe
- 11–50 Beschäftigte
- Hauptsitz
- Berlin, Berlin
- Art
- Nonprofit
- Gegründet
- 2023
- Spezialgebiete
- Parkinson, Forschung, Patientenorganisation, Neurologie, NPO, Patient Empowerment, Gemeinnützigkeit, Big Data, KI, Wissenschaft, Neurodegenerative Erkrankungen und Gesundheit
Orte
-
Primär
Berlin, Berlin 10711, DE
Beschäftigte von Kill Parkinson
-
Marco Hamburger 🤖
Let's #killparkinson. Confident that by combining patient knowledge, big data and AI, we will soon win the war against the great plagues of…
-
Mathias Furch
🎤 Moderator | 🗣️ Speaker | 🩺 Healthcare & Pflege-Experte | 🎧Podcaster
-
Elena Tzerefou
UI/UX Designer @ Vodafone | UX Researcher @ Vodafone UX LAB
-
Christos Gkoutzis
Software Developer @Kill Parkinson | MSc in Information and Communications Technology @UniWA | Mil.Engineering Officer of the Hellenic Army
Updates
-
Good read and a very relevant topic. When people with Parkinson's disease need to be hospitalised, it can be a challenge. But with the right standards, a lot can be achieved. #killparkinson #Parkinsons #Gesundheit #Patientensicherheit #KillParkinsons
The 5 standards you should demand if hospitalized with Parkinson's. If you don't know them, read our free blog on the topic which covers the just covered joint commission commentary. https://lnkd.in/e6fUQjkU
-
Starting your journey with Parkinson’s? The Newly Diagnosed Guide from the Parkinson’s Foundation offers some clear and practical information about how to prepare for your doctor’s appointments, such as writing down and asking key questions: 🌟 Besides taking medications, what specific therapies, exercises or lifestyle changes can help manage my PD? 🌟 How can a physical therapist, occupational therapist, speech-language pathologist, and/or mental health counselor help me? Thank you for sharing Parkinson's Foundation!
The Parkinson’s Foundation Newly Diagnosed Guide is designed to help people with Parkinson’s disease and their loved ones get started on their PD journey, learn more about Parkinson’s, and prepare for upcoming doctor's appointments. If you or a loved one were recently diagnosed with Parkinson’s disease, get your free guide by visiting: https://lnkd.in/gbGHuifR
Newly Diagnosed Guide
parkinson.org
-
It is pure nonsense in research and therapy to treat men and women as medically identical so often. Of course, this applies not only to #Parkinsons, but to a large proportion of diseases. Thank you for sharing Cathy Molohan and Elena Moro #killparkinson
Parkinson's advocate, Public Speaker, International Relations Manager at YUVEDO Foundation, consultant on patient centricity and digital biomarkers
Such an important talk today by @Elena Moro at the #BIDays in #Brussels on #gender and #diversity in #neurology. ❓️Why are we still testing far more male animals than female? ❓️Why are there more men enrolled in #clinical #trials than women? ❓️Why is it up to me to educate my neurologist on the effects of #hormones and #perimenopause on my #Parkinson's symptoms? I call on all #physicians, #researchers and #HCPs to educate themselves on #gender differences and their impact on their areas of expertise. European Federation of Neurological Associations European Academy of Neurology Parkinson's Europe
-
💪
Young Onset Parkinson’s, joy, kindness and gratitude. Here’s my thoughts on choosing joy and gratitude when facing a currently incurable disease and how we should treat all people. This isn’t a pity party post. Nor is it one asking for advice. It’s a genuinely to highlight the syndrome. A progressive and degenerative one that is in many ways, a brutal journey. It’s also to share what I’ve learned about how to deal with the tough times. For me, the outward facing symptoms aren’t the worst. The weird walk, effect on voice, tremors, slow movement, etc aren’t pleasant, but for me they aren’t the worst things. It’s the hidden ones. The symptoms no one sees that you wrestle with daily or periodically. From bladder and bowel issues, struggles with swallowing, fatigue, insomnia, severe apathy and anxiety. All of these unseen by people but are very, very real. After an intense period of travel and quite high demand, combined with grief and a virus, I feel basically done in. My natural optimism is replaced by a deep apathy that can be so severe it’s as if you don’t exist. Totally numbing. I also get something that was previously alien to me; Anxiety - a clinical symptom of PD due to the disruption to pathways in our brains. You know it will pass, and you know this isn’t you but the disease. However no matter how much you tell yourself this, it’s tough. Brutally tough. I’ve learned that you can’t think or pray your way out of it. You have to make conscious choices. Read on. The ongoing depletion of dopamine neurons has a catastrophic effect on people with PD. In my case the very rare young onset variety, typically comes with more dystonia (persistent cramp) depression and dyskinesia (involuntary movements). When I get like this it’s hard to smile. Not just due to the face masking (rigid face muscles that make you look angry or moody) but due to the fact that nothing really feels good. In fact, due to the lack of dopamine, you get very little reward hits due to the lack of the hormone that gives you them. So even good things feel neutral. So what do I do? I have to make conscious choices to be joyful and to choose gratitude. When you do this by disciplined choice gradually things change. I also have to rest. This condition doesn’t make life easy for family, work colleagues and friends either. I’m grateful for those that understand and give me extra grace in these times. I’ll never throw the towel in, that’s not my style. Sometimes though in order to replenish, I need to go dark. If I go quiet, or am slow to reply, now you know why. I’m not being rude or slack, I’m simply dealing with the fight of my life. Usually it only takes a day or so to pull out of the nose dive. Finally, here’s my advice to us all, including me when dealing with people. Be kind. Give the benefit of the doubt. Believe the best. You don’t know what someone is going through. #yopd #parkinsons
-
🧠 Learning from Multiple Sclerosis to Tackle Parkinson's Disease 🧠 A fantastic perspective from Lorraine Kalia and colleagues in Nature Reviews Neurology highlights the journey of disease-modifying therapies (DMTs) for multiple sclerosis (MS) and what Parkinson’s disease (PD) might learn. While MS has seen ~18 DMTs developed, Parkinson’s still has none. One key to MS’s progress? MRI has been a game-changer for diagnosis and outcome measurement. Key insights: > MS has advanced with imaging tools like MRI—essential for tracking and diagnosing. > Reliable outcome measures for PD and progressive MS are urgent priorities. > Subtyping remains challenging, but it’s crucial for applying the right therapy. This paper inspires us with the possibility of adapting these advancements for PD. It’s a call to action for leveraging imaging and other modalities to better understand early stages, with the hope of one day achieving what MS has in treatment options. Read more about these insights here: https://lnkd.in/eAuGDs5r #ParkinsonsDisease #MultipleSclerosis #DiseaseModifyingTherapies #Neurology #MedicalResearch #Imaging #MRI #HopeForACure #ProgressInScience #KillParkinson
-
A great example of how innovations, technology, data and AI can massively simplify the lives of chronically ill and disabled people. Thanks for sharing, and all the best to you @ sadi the Blind Lady #healthinnovation #killparkinsons #ai #parkinson #parkinsons #healthtech https://lnkd.in/eiP2C-Am
-
#levodopa / #ldopa drugs are associated with increasing and severe side effects in long-term therapy of #parkinsonsdisease. Susy Prieto Huarcaya, PhD has been on the hunt for studies evaluating the potential of #mucuna / #mucunapruriens as an alternative, with surprising results. Must read on our blog : https://lnkd.in/ezaaBiah #killparkinson #killparkinsons #pdtherapy
Weniger NW, längere ON-Zeiten, schnellere Wirkung: Mucuna als L-Dopa-Ersatz bei Parkinson?
https://www.kill-parkinson.org
-
Noteworthy News from #ParkinsonsResearch. We like to share exceptional findings from an international research team led by Prof Wolfgang Oertel (Universitätsklinikum Marburg) and Prof. Dr. Michael Strupp (LMU München), published in *Nature Communications*. Their work shows that the modified amino acid Acetyl-DL-Leucin may! prevent Parkinson's disease from progressing in its early stages, offering new hope to those at risk. While studies are needed, this is a promising step towards innovative treatments. #ParkinsonsResearch #KillParkinson #AcetylDLLeucin #DGN #Neurology #ParkinsonsDisease #FightParkinsons #dgn
-
A recent article from ABC News sheds light on growing evidence that the widely used #herbicide, paraquat, may be linked to an increased risk of #Parkinsons. The study suggests that exposure to this farm chemical could potentially damage cells in the brain, leading to the development of the disease. #KillParkinson #ParkinsonsResearch #EnvironmentalFactors 👉 Read the full article here: ABC News - Paraquat and Parkinson's https://lnkd.in/gX_gTWt3 Thanks for sharing Bas Bloem
Professor of Neurology Radboudumc Director Center of Expertise for Parkinson & Movement Disorders Cofounder ParkinsonNet
Astonishing article on the role of industry and regulatory bodies in #Australia in extending the use of #paraquat, a highly toxic #pesticide, despite converging and overwhelming evidence that links exposure to #paraquat to a higher risk of #Parkinson disease, in particular among farmers. Economic interests are clearly more important than the health of farmers, their families and their neighbours. I fear that similar mechanisms may be at play in the authorisation of other pesticides, also elsewhere in the world. Importantly, farmers themselves are not to blame at all, they adhere to what regulatory bodies have approved. The problem is that this regulation does not protect farmers well, and the article describes the devastating impact of Parkinson disease on this community. https://lnkd.in/e8WknHvm The Michael J. Fox Foundation for Parkinson's Research Parkinson's Foundation International Parkinson and Movement Disorder Society Parkinson Vereniging ParkinsonNL Cure Parkinson's Parkinson's UK
Parkinson's has been called the silent pandemic, and scientists believe a common farm chemical could be one cause
abc.net.au